The Results Are In from Quest Diagnostics®

Tick-borne diseases are becoming an increasing concern across the United States, with rising case counts and expanding geographic spread. While Lyme disease remains the most recognized infection, clinicians are now facing a broader range of pathogens and more complex cases involving co-infections. In this episode of The Results Are In from Quest Diagnostics, host Anne Freeman sits down with Dr. An...

Exocrine pancreatic insufficiency (EPI) is an underrecognized but clinically significant condition that can lead to malnutrition, weight loss, and long-term complications if left undiagnosed. Fortunately, there's a noninvasive and highly specific test that can help clinicians take the guesswork out of diagnosis. In this episode of The Results Are In , host Jen Jenkins speaks with Dr Elif Nahas, As...

The evolution of prenatal genetics is transforming care by supporting clarity, confidence, and a patient-centric approach. In this episode of The Results Are In by Quest Diagnostics, host Lisa Demers is joined by Paul Kezmarsky, Director of Strategy & Solutions in Genetics at Quest. A board-certified genetic counselor, Paul brings over a decade of experience across both clinical and laboratory set...

Per- and polyfluoroalkyl substances (PFAS), often called “forever chemicals,” have made their way into drinking water, consumer products, and even our bodies. With potential health risks tied to exposure, PFAS have become one of the most pressing public health challenges today. In this episode of The Results Are In from Quest Diagnostics, host Dr Jack Kain speaks with Dr. Sarah Bartock, National S...

In this episode of Results Are In by Quest Diagnostics, Jen Jenkins is joined by Dr. Meghan W. Starolis, Senior Science Director of Infectious Disease at Quest Diagnostics, to discuss the importance of universal screening for hepatitis B, hepatitis C, and HIV.  Dr. Starolis explains the CDC’s latest recommendations, the real-world impact of co-infections, and why regular testing is critical even f...

Across oncology care, clinicians are facing a growing demand for precision tools that go beyond standard imaging and protein biomarkers. In this episode of Results Are In by Quest Diagnostics, host Jesus Izaguirre-Carbonell welcomes Dr. Thomas P. Slavin Jr., Chief Clinical Officer of Molecular Oncology and Medical Director for Haystack MRD at Quest, for a focused conversation on minimal residual d...

In this episode of Results are In by Quest Diagnostics, Dr. Jack Kain joins Jason Suomala to explain the threat of novel psychoactive substances and how Quest's updated testing panel helps providers identify what's being used and treat patients with more confidence.  They break down what providers need to know about NPS classes like designer benzodiazepines, fentanyl analogs, synthetic cannabinoid...

In this episode of Results are In by Quest Diagnostics, Amanda Benson is joined by Dr. Michael Racke, Medical Director for Neurology at Quest Diagnostics, to discuss the groundbreaking role blood-based biomarkers play in assessing Alzheimer’s disease risk. Dr. Racke shares his expert insights on how these biomarkers are revolutionizing early risk detection and diagnosis, offering primary care phys...

Welcome to The Results Are In from Quest Diagnostics, where host Amanda Benson dives into the critical role of diagnostics in shaping the future of healthcare. Join industry-leading experts as they explore how comprehensive testing supports faster, more effective care and drives better patient outcomes across a wide range of clinical areas. From uncovering insights through Quest’s industry-leading...